SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000878088-11-000063
Filing Date
2011-08-03
Accepted
2011-08-03 16:44:34
Documents
13
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q f2ndqtr1110qfinaledgar.htm 10-Q 1348332
2 AMENDED & RESTATED 1997 DIRECTORS' STOCK & DEFERRED FEE PLAN f10q6302011exhibitamendmentt.htm EX-10.1 4036
3 SHARE PURCHASE AGREEMENT sharepurchaseagm51711ctrfor1.htm EX-10.2 478207
4 CERTIFICATION exhibit31ceocert.htm EX-31.1 7236
5 CERTIFICATION exhibit31cfocert.htm EX-31.2 7311
6 CERTIFICATION exhibit32ceo.htm EX-32.1 3525
7 CERTIFICATION exhibit32cfo.htm EX-32.2 3988
  Complete submission text file 0000878088-11-000063.txt   14052009

Data Files

Seq Description Document Type Size
8 prx-20110630.xml EX-101.INS 3010494
9 prx-20110630.xsd EX-101.SCH 70534
10 prx-20110630_cal.xml EX-101.CAL 64628
11 prx-20110630_lab.xml EX-101.LAB 481491
12 prx-20110630_pre.xml EX-101.PRE 385346
13 prx-20110630_def.xml EX-101.DEF 165469
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 111007431
SIC: 2834 Pharmaceutical Preparations